Published in Psychopharmacology (Berl) on December 19, 2006
Are DBA/2 mice associated with schizophrenia-like endophenotypes? A behavioural contrast with C57BL/6 mice. Psychopharmacology (Berl) (2009) 0.87
Neuroleptic drugs revert the contextual fear conditioning deficit presented by spontaneously hypertensive rats: a potential animal model of emotional context processing in schizophrenia? Schizophr Bull (2008) 0.83
A new model of the disrupted latent inhibition in C57BL/6J mice after bupropion treatment. Psychopharmacology (Berl) (2009) 0.80
D-amphetamine and antipsychotic drug effects on latent inhibition in mice lacking dopamine D2 receptors. Neuropsychopharmacology (2013) 0.80
The effects of breeding protocol in C57BL/6J mice on adult offspring behaviour. PLoS One (2011) 0.77
Sex-specific positive and negative consequences of avoidance training during childhood on adult active avoidance learning in mice. Front Behav Neurosci (2013) 0.77
Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci (2005) 16.18
Context, time, and memory retrieval in the interference paradigms of Pavlovian learning. Psychol Bull (1993) 6.87
From motivation to action: functional interface between the limbic system and the motor system. Prog Neurobiol (1980) 5.46
Brain dopamine and reward. Annu Rev Psychol (1989) 4.41
Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci (2002) 4.02
Failure to escape traumatic shock. J Exp Psychol (1967) 3.11
Latent inhibition: the effect of nonreinforced pre-exposure to the conditional stimulus. J Comp Physiol Psychol (1959) 3.07
Dopamine and the regulation of cognition and attention. Prog Neurobiol (2002) 2.72
The validity of animal models of depression. Psychopharmacology (Berl) (1984) 2.07
Effects of inescapable shock upon subsequent escape and avoidance responding. J Comp Physiol Psychol (1967) 2.01
Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment. Ann N Y Acad Sci (2003) 1.92
Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev (2005) 1.70
Multiparous species present problems (and possibilities) to developmentalists. Dev Psychobiol (1997) 1.69
Pharmacology and behavioral pharmacology of the mesocortical dopamine system. Prog Neurobiol (2001) 1.65
The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology (Berl) (2003) 1.49
Learned helplessness and animal models of depression. Prog Neuropsychopharmacol Biol Psychiatry (1984) 1.47
Immunological stress at the maternal-foetal interface: a link between neurodevelopment and adult psychopathology. Brain Behav Immun (2005) 1.27
Differential performance of acute and chronic schizophrenics in a latent inhibition task. J Nerv Ment Dis (1988) 1.27
Integrating schizophrenia. Schizophr Bull (1998) 1.17
Learned helplessness in the rat: improvements in validity and reliability. Brain Res Brain Res Protoc (2001) 1.17
Neurotransmitter interactions in schizophrenia--therapeutic implications. Biol Psychiatry (1999) 1.16
The schizophrenic experience: taken out of context? Schizophr Bull (2005) 1.11
Latent inhibition in humans: data, theory, and implications for schizophrenia. Psychol Bull (1995) 1.08
Construct validity of the animal latent inhibition model of selective attention deficits in schizophrenia. Schizophr Bull (2005) 1.08
Neural substrates of latent inhibition: the switching model. Psychol Bull (1990) 1.06
Antidepressant-like effects of dopamine agonists in an animal model of depression. Biol Psychiatry (1992) 1.04
Associative and nonassociative theories of the UCS preexposure phenomenon: implications for Pavlovian conditioning. Psychol Bull (1979) 1.03
Prenatal and postnatal maternal contributions in the infection model of schizophrenia. Exp Brain Res (2006) 1.03
Dopamine and depression: a review of recent evidence. I. Empirical studies. Brain Res (1983) 1.02
The pharmacology of latent inhibition as an animal model of schizophrenia. Brain Res Brain Res Rev (2000) 0.99
Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man. Psychopharmacology (Berl) (1992) 0.96
The effect of amphetamine on Kamin blocking and overshadowing. Behav Pharmacol (2003) 0.94
Learned helplessness in the rat: time course, immunization, and reversibility. J Comp Physiol Psychol (1975) 0.94
Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats. Psychopharmacology (Berl) (1984) 0.93
Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: relationship to schizophrenic attention disorder. Biol Psychiatry (1981) 0.93
Contextual conditioning and the US preexposure effect in conditioned fear. J Exp Psychol Anim Behav Process (1981) 0.92
Disruption of selective attention in the rat following chronic d-amphetamine administration: relationship to schizophrenic attention disorder. Biol Psychiatry (1982) 0.90
Ibotenate lesions of the hippocampus enhance latent inhibition in conditioned taste aversion and increase resistance to extinction in conditioned taste preference. Behav Neurosci (1993) 0.88
Enhancement of latent inhibition in rats with electrolytic lesions of the hippocampus. Behav Neurosci (1995) 0.87
Repeated treatment with imipramine, fluvoxamine and tranylcypromine decreases the number of escape failures by activating dopaminergic systems in a rat learned helplessness test. Life Sci (2001) 0.86
Disruption of latent inhibition by acute administration of low doses of amphetamine. Pharmacol Biochem Behav (1988) 0.84
The role of habituation of the response to LiCl in the US-preexposure effect. Learn Behav (2005) 0.84
Dopamine receptors and learned helplessness in the rat: an autoradiographic study. Prog Neuropsychopharmacol Biol Psychiatry (2002) 0.84
Latent inhibition of conditioned taste aversion is not disrupted, but can be enhanced, by selective nucleus accumbens shell lesions in rats. Neuroscience (2005) 0.83
The role of mesolimbic and nigrostriatal dopamine in latent inhibition as measured with the conditioned taste aversion paradigm. Psychopharmacology (Berl) (1997) 0.83
Dopaminergic and opioidergic mediations of tricyclic antidepressants in the learned helplessness paradigm. Pharmacol Biochem Behav (1999) 0.83
S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole. J Pharmacol Exp Ther (2004) 0.83
The US-preexposure effect in lithium-induced flavor-aversion conditioning is a consequence of blocking by injection cues. J Exp Psychol Anim Behav Process (2004) 0.82
Expression of the CS- and US-pre-exposure effects in the conditioned taste aversion paradigm and their abolition following systemic amphetamine treatment in C57BL6/J mice. Neuropsychopharmacology (2004) 0.82
Nucleus accumbens, entorhinal cortex and latent inhibition: a neural network model. Behav Brain Res (2001) 0.82
Haloperidol reinstates latent inhibition impaired by hippocampal lesions: data and theory. Behav Neurosci (2000) 0.82
Perplexing effects of hippocampal lesions on latent inhibition: a neural network solution. Behav Neurosci (1998) 0.81
Disruption of the Kamin blocking effect in schizophrenia and in normal subjects following amphetamine. Behav Brain Res (1997) 0.81
Dorsal hippocampal lesions impair blocking but not latent inhibition of taste aversion learning in rats. Behav Neurosci (1995) 0.81
Effects of nicotine and amphetamine on latent inhibition in human subjects. Psychopharmacology (Berl) (1996) 0.81
Brain-behaviour relationships in latent inhibition: a computational model. Neurosci Biobehav Rev (2005) 0.80
Characteristics of the lithium-mediated proximal US-preexposure effect in flavor-aversion conditioning. Anim Learn Behav (1979) 0.79
The role of injection cues in the associative control of the US pre-exposure effect in flavour aversion learning. Q J Exp Psychol B (2003) 0.79
Associative effects of US preexposure: modulation of conditioned responding by an excitatory training context. J Exp Psychol Anim Behav Process (1987) 0.79
Differential effects of microinjections of d-amphetamine into the nucleus accumbens or the caudate putamen on the rat's ability to ignore an irrelevant stimulus. Biol Psychiatry (1982) 0.78
The influence of selective lesions to components of the hippocampal system on the orienting [correction of orientating] response, habituation and latent inhibition. Eur J Neurosci (2002) 0.78
Haloperidol and clozapine antagonise amphetamine-induced disruption of latent inhibition of conditioned taste aversion. Psychopharmacology (Berl) (2003) 0.77
From an animal model of an attentional deficit towards new insights into the pathophysiology of schizophrenia. J Psychiatr Res (1992) 0.77
CS-US preexposure effects on trace eyeblink conditioning in young rats: potential implications for functional brain development. Behav Neurosci (2006) 0.77
Reversal of learned helplessness by morphine in rats: involvement of a dopamine mediation. Pharmacol Biochem Behav (1998) 0.75
Role of stimulus locale on strain differences in active avoidance after scopolamine of D-amphetamine treatment. Pharmacol Biochem Behav (1976) 0.75
Drug-preexposure effects in flavor-aversion learning: associative interference by conditioned environmental stimuli. J Exp Psychol Anim Behav Process (1979) 0.75
Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science (2013) 3.83
The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci (2006) 3.03
Mesolimbic dopaminergic pathways in fear conditioning. Prog Neurobiol (2004) 2.38
Abnormal differentiation of newborn granule cells in age-related working memory impairments. Neurobiol Aging (2008) 2.38
Adult brain and behavioral pathological markers of prenatal immune challenge during early/middle and late fetal development in mice. Brain Behav Immun (2007) 1.86
Long-term neurobehavioural impact of the postnatal environment in rats: manipulations, effects and mediating mechanisms. Neurosci Biobehav Rev (2003) 1.78
In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neurosci Biobehav Rev (2009) 1.74
Epidemiology-driven neurodevelopmental animal models of schizophrenia. Prog Neurobiol (2009) 1.73
Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev (2005) 1.70
Long-term effects of early-life environmental manipulations in rodents and primates: Potential animal models in depression research. Neurosci Biobehav Rev (2005) 1.70
Effect of social isolation on stress-related behavioural and neuroendocrine state in the rat. Behav Brain Res (2004) 1.65
Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation? Pediatr Res (2011) 1.62
Enhanced recognition memory following glycine transporter 1 deletion in forebrain neurons. Behav Neurosci (2007) 1.56
Double dissociation of the effects of selective nucleus accumbens core and shell lesions on impulsive-choice behaviour and salience learning in rats. Eur J Neurosci (2005) 1.54
A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr Bull (2008) 1.49
Hippocampal modulation of sensorimotor processes. Prog Neurobiol (2003) 1.47
Transduction profiles of recombinant adeno-associated virus vectors derived from serotypes 2 and 5 in the nigrostriatal system of rats. J Virol (2004) 1.45
The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse? Neuroscientist (2007) 1.42
Dissociation of function between the dorsal and the ventral hippocampus in spatial learning abilities of the rat: a within-subject, within-task comparison of reference and working spatial memory. Eur J Neurosci (2004) 1.42
Genetic ablation of tumor necrosis factor-alpha (TNF-alpha) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum. J Neurochem (2004) 1.38
Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice. J Neuroinflammation (2012) 1.36
Dorsal hippocampus and classical fear conditioning to tone and context in rats: effects of local NMDA-receptor blockade and stimulation. Hippocampus (2003) 1.35
Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain. Nat Rev Drug Discov (2013) 1.27
Immunological stress at the maternal-foetal interface: a link between neurodevelopment and adult psychopathology. Brain Behav Immun (2005) 1.27
A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia. J Neurosci (2010) 1.24
Disruption of glycine transporter 1 restricted to forebrain neurons is associated with a procognitive and antipsychotic phenotypic profile. J Neurosci (2006) 1.23
Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia. Int J Neuropsychopharmacol (2008) 1.21
GABA receptors containing the alpha5 subunit mediate the trace effect in aversive and appetitive conditioning and extinction of conditioned fear. Eur J Neurosci (2004) 1.21
Relative prenatal and postnatal maternal contributions to schizophrenia-related neurochemical dysfunction after in utero immune challenge. Neuropsychopharmacology (2007) 1.18
Specific neuronal protein: a new tool for histological evaluation of excitotoxic lesions. Physiol Behav (2002) 1.17
Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels. Neuropsychopharmacology (2007) 1.13
Performance of the marmoset monkey on computerized tasks of attention and working memory. Brain Res Cogn Brain Res (2004) 1.12
Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia. Neuropsychopharmacology (2010) 1.12
Effect of excitotoxic lesions of rat medial prefrontal cortex on spatial memory. Behav Brain Res (2002) 1.11
Prenatal immune challenge is an environmental risk factor for brain and behavior change relevant to schizophrenia: evidence from MRI in a mouse model. PLoS One (2009) 1.10
The impact of voluntary exercise on mental health in rodents: a neuroplasticity perspective. Behav Brain Res (2008) 1.09
The International Society for Developmental Psychobiology annual meeting symposium: Impact of early life experiences on brain and behavioral development. Dev Psychobiol (2006) 1.08
DJ-1 and Parkin modulate dopamine-dependent behavior and inhibit MPTP-induced nigral dopamine neuron loss in mice. Mol Ther (2007) 1.08
Early deprivation and behavioral and physiological responses to social separation/novelty in the marmoset. Pharmacol Biochem Behav (2002) 1.07
Evaluating early preventive antipsychotic and antidepressant drug treatment in an infection-based neurodevelopmental mouse model of schizophrenia. Schizophr Bull (2008) 1.07
A novel pregnane X receptor and S14-mediated lipogenic pathway in human hepatocyte. Hepatology (2009) 1.06
Effects of typical and atypical antipsychotics on prepulse inhibition and latent inhibition in chronic schizophrenia. Biol Psychiatry (2002) 1.06
ApoE4 impairs hippocampal plasticity isoform-specifically and blocks the environmental stimulation of synaptogenesis and memory. Neurobiol Dis (2003) 1.06
Neural basis of psychosis-related behaviour in the infection model of schizophrenia. Behav Brain Res (2008) 1.05
Influence of differential housing on emotional behaviour and neurotrophin levels in mice. Behav Brain Res (2006) 1.05
Disruption of hippocampus-regulated behavioural and cognitive processes by heterozygous constitutive deletion of SynGAP. Eur J Neurosci (2010) 1.05
Early life stress: long-term physiological impact in rodents and primates. News Physiol Sci (2002) 1.03
Prenatal and postnatal maternal contributions in the infection model of schizophrenia. Exp Brain Res (2006) 1.03
Age-related accumulation of Reelin in amyloid-like deposits. Neurobiol Aging (2007) 1.02
Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy. Neuropharmacology (2011) 1.02
Selective inactivation of adenosine A(2A) receptors in striatal neurons enhances working memory and reversal learning. Learn Mem (2011) 1.01
To poly(I:C) or not to poly(I:C): advancing preclinical schizophrenia research through the use of prenatal immune activation models. Neuropharmacology (2011) 1.01
Prenatal exposure to infection: a primary mechanism for abnormal dopaminergic development in schizophrenia. Psychopharmacology (Berl) (2009) 1.01
Transgenic overexpression of adenosine kinase in brain leads to multiple learning impairments and altered sensitivity to psychomimetic drugs. Eur J Neurosci (2007) 1.00
A differential involvement of the shell and core subterritories of the nucleus accumbens of rats in memory processes. Behav Neurosci (2003) 1.00
On the influence of baseline startle reactivity on the indexation of prepulse inhibition. Behav Neurosci (2008) 1.00
Prenatal immune activation induces maturation-dependent alterations in the prefrontal GABAergic transcriptome. Schizophr Bull (2013) 1.00
Dopamine-dependent neurodegeneration in rats induced by viral vector-mediated overexpression of the parkin target protein, CDCrel-1. Proc Natl Acad Sci U S A (2003) 1.00
The postweaning social isolation in C57BL/6 mice: preferential vulnerability in the male sex. Psychopharmacology (Berl) (2008) 1.00
Effect of a single maternal separation at different pup ages on the corticosterone stress response in adult and aged rats. Pharmacol Biochem Behav (2002) 0.99
Deprivation of parenting disrupts development of homeostatic and reward systems in marmoset monkey offspring. Biol Psychiatry (2004) 0.99
Inhibition of glycine transporter 1: The yellow brick road to new schizophrenia therapy? Curr Pharm Des (2015) 0.99
Early parental deprivation in the marmoset monkey produces long-term changes in hippocampal expression of genes involved in synaptic plasticity and implicated in mood disorder. Neuropsychopharmacology (2008) 0.99
Glycine transporter 1 as a potential therapeutic target for schizophrenia-related symptoms: evidence from genetically modified mouse models and pharmacological inhibition. Biochem Pharmacol (2011) 0.98
Effects of prenatal dexamethasone treatment on postnatal physical, endocrine, and social development in the common marmoset monkey. Endocrinology (2007) 0.98
Prenatal immune activation interacts with genetic Nurr1 deficiency in the development of attentional impairments. J Neurosci (2012) 0.98
Chronic clozapine treatment improves prenatal infection-induced working memory deficits without influencing adult hippocampal neurogenesis. Psychopharmacology (Berl) (2009) 0.97
The Effects of dizocilpine and phencyclidine on prepulse inhibition of the acoustic startle reflex and on prepulse-elicited reactivity in C57BL6 mice. Neuropsychopharmacology (2004) 0.97